First phase began in July 2017 and has just been completed
Distribution agreement to supply range of state-of-the-art sonication systems for DNA fragmentation
Analyzers address growing demand by labs in need of a product to document their Heparin Anti-Xa linearity and calibration verification
Q and A will also follow the discussion
In recognition of medical focus to research he and his team conducted on development and standardisation of molecular diagnostics
Hub will address manufacturing, business and regulatory challenges to ensure new targeted biological medicines can be developed quickly
LGC operates out of 22 countries, with laboratories and centres across Europe and the US, as well as sites in Brazil, China and India.